BLOG

Saturday, December 1, 2018

Sebi starts probe against Sun Pharma, to also reopen insider trading case

The whistle-blower accused the company of committing corporate governance and tax-related lapses, besides other securities market-related violations

from Home Page https://ift.tt/2rgpe1c
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...